AMUB
AMUB 1-star rating from Upturn Advisory

UBS AG London Branch ELKS 5 (AMUB)

UBS AG London Branch ELKS 5 (AMUB) 1-star rating from Upturn Advisory
$21.69
Last Close (24-hour delay)
Profit since last BUY11.34%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 28 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

02/20/2026: AMUB (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Advertisement

Key Highlights

Volume (30-day avg) -
Beta 0.84
52 Weeks Range 16.16 - 20.50
Updated Date 06/29/2025
52 Weeks Range 16.16 - 20.50
Updated Date 06/29/2025
Advertisement

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

UBS AG London Branch ELKS 5

UBS AG London Branch ELKS 5(AMUB) company logo displayed in Upturn AI summary

ETF Overview

overview logo Overview

The UBS AG London Branch ELKS 5 is a structured product, not a traditional ETF, offering leveraged exposure to a reference asset. It is designed for sophisticated investors seeking enhanced returns linked to the performance of a specific underlying index or security, typically with a capital-at-risk component.

Reputation and Reliability logo Reputation and Reliability

UBS AG is a globally recognized financial services company with a long-standing reputation in investment banking and wealth management. Its London Branch operates under strict regulatory frameworks, indicating a degree of reliability.

Leadership icon representing strong management expertise and executive team Management Expertise

While not managed in the traditional ETF sense, the creation and structuring of ELKS products are handled by specialized teams within UBS, drawing on their expertise in derivatives and structured finance.

Investment Objective

Icon representing investment goals and financial objectives Goal

To provide investors with leveraged participation in the performance of a specific underlying asset, often with a defined maturity date and potential for capital loss.

Investment Approach and Strategy

Strategy: This is a structured note (ELKS - Equity Linked Certificates) designed to mirror or amplify the performance of a reference asset, such as an equity index or a single stock. It is not an index-tracking ETF.

Composition ELKS are derivative instruments. Their composition is based on a contract with the issuer (UBS AG) linked to the performance of an underlying asset. They do not hold physical assets like stocks or bonds directly.

Market Position

Market Share: As a structured product, direct market share comparison to traditional ETFs is not applicable. Market share is more relevant within the structured products sector.

Total Net Assets (AUM): Data for AUM of specific ELKS tranches is typically not publicly disclosed in the same manner as traditional ETFs. The value is tied to the terms of the specific note.

Competitors

Key Competitors logo Key Competitors

  • Other structured note providers (e.g., Goldman Sachs, JPMorgan Chase, Morgan Stanley)
  • ETFs offering similar underlying asset exposure (if applicable, but with different risk/return profiles)

Competitive Landscape

The competitive landscape for structured products like ELKS involves other investment banks offering similar bespoke or standardized notes. The primary advantages are potential for amplified returns and tailored risk profiles, but the disadvantages include complexity, opacity, counterparty risk, and potential for full capital loss.

Financial Performance

Historical Performance: Historical performance is highly specific to the terms of each individual ELKS issuance, including the underlying asset, maturity date, and payoff structure. General historical data for 'UBS AG London Branch ELKS 5' as a generic entity is not available.

Benchmark Comparison: ELKS are not designed to track a benchmark index in the traditional sense. Their performance is directly linked to the reference asset's performance, potentially with leverage or participation rates.

Expense Ratio: ELKS do not have a traditional expense ratio. The costs are embedded within the pricing of the note, reflecting the issuer's costs, risk premium, and embedded derivative components.

Liquidity

Average Trading Volume

Liquidity for specific ELKS issuances can be limited, and trading volume is not consistently reported like for major ETFs.

Bid-Ask Spread

The bid-ask spread can be wide for less liquid structured products, reflecting the dealer's inventory risk and the complexity of the instrument.

Market Dynamics

Market Environment Factors

Performance is heavily influenced by the price movements of the underlying reference asset (e.g., equity indices, commodities). Broader market sentiment, interest rates, and volatility also play a significant role.

Growth Trajectory

Growth is tied to the demand for structured products and the specific market view on the underlying asset. The issuance of new ELKS series depends on market opportunities and investor appetite.

Moat and Competitive Advantages

Competitive Edge

UBS AG's competitive edge lies in its global reach, established reputation in derivatives and structured products, and its ability to structure complex payoffs tailored to specific market views. The ELKS offer potentially amplified exposure to an underlying asset, appealing to investors seeking higher returns, albeit with commensurate risk.

Risk Analysis

Volatility

The volatility of an ELKS is directly tied to the volatility of its underlying reference asset, potentially magnified by leverage. Investors face significant downside risk.

Market Risk

Market risk for ELKS includes the risk of the underlying asset declining in value, potentially leading to a partial or total loss of invested capital. There is also counterparty risk, as the investor relies on UBS AG to fulfill its obligations.

Investor Profile

Ideal Investor Profile

Sophisticated investors with a high-risk tolerance, a strong understanding of derivatives and structured products, and a specific, often short-to-medium term, outlook on the underlying asset.

Market Risk

Best suited for active traders or sophisticated investors looking for specific, leveraged exposure to an underlying asset, rather than passive, long-term index followers.

Summary

UBS AG London Branch ELKS 5 represents structured notes offering leveraged exposure to a reference asset. They are not traditional ETFs and carry significant risk, including the potential for total capital loss. Performance is highly dependent on the underlying asset's movement and the specific terms of the ELKS issuance. These instruments are designed for sophisticated investors with a high-risk tolerance.

Similar ETFs

Sources and Disclaimers

Data Sources:

  • Information based on general knowledge of structured products and ELKS.
  • Specific terms of any ELKS issuance would require direct consultation of offering documents.

Disclaimers:

This information is for educational purposes only and does not constitute investment advice. Structured products like ELKS are complex and involve substantial risks, including the potential loss of principal. Investors should consult with a qualified financial advisor before making any investment decisions and review all offering documentation carefully.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About UBS AG London Branch ELKS 5

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (the "Securities") is senior unsecured debt securities issued by UBS. The index measures the composite performance of energy master limited partnerships ("MLPs"), and is calculated by S&P Dow Jones Indices using a float-adjusted, capitalization-weighted methodology.